HIV gp140 protein/DNA vaccine (Xenetic Biosciences/Pharmasynthez)

N/A

Report date: 2025/10/28 17:51:05

Base Information

Drug NameHIV gp140 protein/DNA vaccine (Xenetic Biosciences/Pharmasynthez)
Drug Alias NameHIV gp140 protein/DNA vaccine (Lipoxen/Pharmasynthez)HIVirinHIVirion
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineBiologics > Protein drugs > Recombinant polypeptide +[5] 
Mechanisms of ActionViral nonstructural proteins modulators
TargetsViral nonstructural proteins
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian FederationUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesXenetic Biosciences (Uk) Ltd
China Registration ClassN/A

Develop Information

Active CompaniesXenetic Biosciences (Uk) LtdPharmsynthez
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A